Protection against graft-versus-host disease by large doses of donor CD4+ T cells: a novel approach to bone marrow transplantation.
Heath
W R
WR
Walter and Eliza Hall Institute, Parkville, Victoria, Australia.
Miller
J F
JF
Sprent
J
J
D000818:Animals; D016026:Bone Marrow Transplantation / Q000276:immunology*; D015704:CD4 Antigens / Q000276:immunology*; D003433:Crosses, Genetic; D006085:Graft Survival / Q000276:immunology; D006086:Graft vs Host Disease / Q000517:prevention & control*; D006183:H-2 Antigens / Q000276:immunology; D006649:Histocompatibility Antigens / Q000276:immunology; D016219:Immunotherapy, Adoptive; D007942:Leukemia, Experimental / Q000276:immunology / Q000601:surgery; D051379:Mice; D008807:Mice, Inbred BALB C; D008815:Mice, Inbred Strains; D013154:Spleen / Q000276:immunology; D016176:T-Lymphocyte Subsets / Q000276:immunology*
D015704:CD4 Antigens; D006183:H-2 Antigens; D006649:Histocompatibility Antigens